Details for Patent: 7,910,131
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 7,910,131 protect, and when does it expire?
Patent 7,910,131 protects OXTELLAR XR and is included in one NDA.
This patent has fourteen patent family members in ten countries.
Summary for Patent: 7,910,131
Title: | Method of treating seizures using modified release formulations of oxcarbazepine |
Abstract: | Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed. |
Inventor(s): | Bhatt; Padmanabh P. (Rockville, MD), Kidane; Argaw (Montgomery Village, MD), Edwards; Kevin (Lovettsville, VA) |
Assignee: | Supernus Pharmaceuticals, Inc. (Rockville, MD) |
Application Number: | 12/230,276 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,910,131 |
Patent Claim Types: see list of patent claims | Use; Formulation; Dosage form; Composition; |
Drugs Protected by US Patent 7,910,131
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Supernus Pharms | OXTELLAR XR | oxcarbazepine | TABLET, EXTENDED RELEASE;ORAL | 202810-001 | Oct 19, 2012 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | TREATMENT OF PARTIAL-ONSET SEIZURES | See Plans and Pricing | ||||
Supernus Pharms | OXTELLAR XR | oxcarbazepine | TABLET, EXTENDED RELEASE;ORAL | 202810-002 | Oct 19, 2012 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | TREATMENT OF PARTIAL-ONSET SEIZURES | See Plans and Pricing | ||||
Supernus Pharms | OXTELLAR XR | oxcarbazepine | TABLET, EXTENDED RELEASE;ORAL | 202810-003 | Oct 19, 2012 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | TREATMENT OF PARTIAL-ONSET SEIZURES | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,910,131
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 496623 | See Plans and Pricing | |||
Australia | 2007242984 | See Plans and Pricing | |||
Canada | 2597740 | See Plans and Pricing | |||
China | 101489560 | See Plans and Pricing | |||
Germany | 602007012236 | See Plans and Pricing | |||
European Patent Office | 2026815 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |